Insiders · Profile

Kamal Fariborz

See Remarks at 4D Molecular Therapeutics. Filing since 15 Dec 2020. CIK 0001834020

Company

Date

Role

Action

Shares

Amount

Of holding

FDMT 4D Molecular Therapeutics, Inc.

15 Dec 2020

See Remarks

Bought

4,347

$99.98K

opened

1 decision on file.